The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on March 22, 2018 at the USPTO Headquarters (Alexandria, VA). The agenda for the meeting is as follows: • Welcoming and Opening Remarks (10:00 – 10:10 am EDT) — Daniel Sullivan and Andrew Wang, Directors, TC1600, USPTO • Obviousness of Biologics: Identifying the Biggest Challenges (10:10 – 11:00 am) — Carla Mouta-Bellum of Arrigo, Lee, Guttman & Mouta-Bellum LLP • 103 KSR Rationales (11:00 – 11:50 am) — Lora Driscoll, QAS, TC1600, USPTO • Lunch (11:50 am – 12:50 pm) • 112(f)-New Form Paragraphs…Original Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.